세계의 전기 의료 및 생체 전기 의료 시장 : 제품(심장 페이스메이커, ICD, 인공 내이, 신경 조절), 유형, 용도별 예측(-2029년)
Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation ), Type, Application - Global Forecast to 2029
상품코드:1452895
리서치사:MarketsandMarkets
발행일:2024년 03월
페이지 정보:영문 382 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
전기 의료 및 생체 전기 의료 및 생체 전기 의료 규모는 예측 기간 동안 복합 연간 성장률(CAGR) 7.0%로 추이되며 2024년 239억 달러에서 2029년 336억 달러 규모에 달할 것으로 예측됩니다.
이 시장 성장의 주요 요인으로는 심장 리듬 관리(CRM) 장치의 연구 투자 및 자금 투입 증가, 신경 질환에 대한 정부 지원 및 자금 제공 증가, 신경 질환 및 심혈관 질환 유병 비율의 상승으로 이어지는 노령 인구 증가 등을 들 수 있습니다. 한편, 전기 의료 장치의 비용이 높고, 엄청난 설비 투자가 필요하다는 것은 시장 성장을 억제하고 있습니다.
조사 범위
조사 대상년도
2021-2029년
기준년
2023년
예측 기간
2024년-2029년
단위
금액(달러)
부문
제품 유형, 용도 및 지역별
대상 지역
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 & 아프리카
예측 기간 동안 망막 이식 부서가 최대 성장률을 보여줄 전망 :
망막 이식는 망막 색소 변성 및 노화 황반 변성과 같은 망막 변성 질환 환자의 시력을 회복시킬 수 있으며 성장이 촉진되고 있습니다.
비침습 전자 슈팅 장치의 부서가 예측 기간 동안 가장 높은 수익 성장률을 보여줄 전망:
이러한 장치는 외과적 이식을 필요로 하지 않으며, 대신에 전계와 자기장을 사용하여 신체 표면의 신경과 근육을 자극합니다. 사용하기 쉽고 비용 효과적이며 감염 위험도 낮습니다. 비침습 일렉트로슈티칼스는 만성 통증, 신경 장애, 대사 장애의 치료에 점점 더 많이 사용되고 있습니다. 이 장치의 기술 진보와 의료 지출 증가와 만성 질환의 유병률의 상승도 예측 기간 동안의 성장을 가속할 것으로 예상됩니다.
아시아태평양이 가장 성장하는 지역에 :
아시아태평양은 예측 기간 동안 가장 높은 복합 연간 성장률(CAGR) 기록할 것으로 예상됩니다. 이 성장은 의료 지출 증가, 약물 R&D 증가, 질병 조기 발견에 대한 의식 향상을 위한 정부의 이니셔티브, 각국의 농촌로의 민간 병원 확대, 지역 내 고성장 시장 존재 등 요인 때문입니다.
본 보고서에서는 세계 일렉트로슈티컬스/생체전기의료 시장을 조사했으며,, 시장 개요, 시장영향인자 및 시장 기회 분석, 기술,특허 동향, 법규제 환경, 시장 규모 추이와 예측, 각종 구분,지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
제5장 시장 개요
시장 역학
성장 촉진요인
억제요인
기회
과제
동향
가격 분석
밸류체인 분석
공급망 분석
생태계 분석
Porter's Five Forces 분석
규제 상황
기술 분석
무역 분석
특허 분석
주요 회의 및 이벤트
고객의 비즈니스에 영향을 미치는 동향/혁신
주요 이해관계자와 구매 기준
제6장 전기 의료 및 생체 전기 의료 시장 : 제품별
심장 페이스메이커 및 이식형 제세동기
인공 내이
신경조절물질
척수 자극 장치
심부뇌자극장치
미주 신경 자극 장치
천골 신경 자극제
위 전기 자극 장치
경피적 전기신경자극장치
경두개 자기 자극기
호흡기 전기자극장치
미샤 신경 자극제
반응성 신경 자극 물질
망막 이식
제7장 전기 의료 및 생체 전기 의료 시장 : 유형별
임베디드 일렉트로슈티컬 디바이스
비침습 일렉트로슈티컬 디바이스
제8장 전기 의료 및 생체 전기 의료 시장 : 용도별
심장 페이스메이커 및 ICD용 : 용도별
부정맥
심부전
기타
척수 자극기용 : 용도별
만성 통증
허리 수술 실패 증후군
허혈
심부뇌자극장치용 : 용도별
파킨슨병
떨림
우울
기타
천골신경자극장치용 : 용도별
요실금
편실금
미주 신경 자극기용 : 용도별
간질
기타
위 전기 자극기용 : 용도별
위부전 마비
비만
경피적 전기 신경 자극기용 : 용도별
치료 저항성 우울증
기타
경두개 자기 자극기용 : 용도별
우울
편두통
호흡기 전기 자극기용 : 용도별
척수 손상
3차 신경 자극기용 : 용도별
주의 결함/다동성 장애
편두통
제9장 전기 의료 및 생체 전기 의료 시장 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
제10장 경쟁 구도
개요
주요 기업의 채용 전략/유력 기업
수익 분석
시장 점유율 분석
브랜드/제품 비교
기업 평가 매트릭스 : 주요 기업
기업 실적
기업 평가 매트릭스 : 스타트업/중소기업
경쟁 벤치마킹
경쟁 시나리오
제11장 기업 프로파일
주요 기업
MEDTRONIC
BOSTON SCIENTIFIC CORPORATION
ABBOTT
LIVANOVA PLC
COCHLEAR LTD.
MICROPORT SCIENTIFIC CORPORATION
SONOVA
NEVRO CORP.
AXONICS, INC.
NEURONETICS
ELECTROCORE, INC.
NEUROPACE, INC.
기타 기업
BIOTRONIK
MEDICO SRL
ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
MED-EL
ALEVA NEUROTHERAPEUTICS
NEUROSIGMA, INC.
BIOWAVE CORPORATION
SOTERIX MEDICAL INC.
BIOINDUCTION(AMBER THERAPEUTICS)
GIMER MEDICAL
CEFALY
BIOCONTROL MEDICAL
TVNS HEALTH GMBH
제12장 부록
BJH
영문 목차
영문목차
The global market for electroceuticals/bioelectric medicine is expected to grow to USD 33.6 billion by 2029, up from USD 23.9 billion in 2024, representing a CAGR of 7.0% during the forecast period. This growth is being primarily driven by several factors, including increased investments and funding for research on cardiac rhythm management (CRM) devices, rising government support and funding for neurological disorders, and the growing geriatric population, which is leading to a higher prevalence of neurological and cardiovascular disorders. However, the market's growth is being hindered by the high cost of electroceutical devices and the need for significant capital investments.
Scope of the Report
Years Considered for the Study
2021-2029
Base Year
2023
Forecast Period
2024-2029
Units Considered
Value (USD) Billion
Segments
Product, type, application, and region
Regions covered
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
"The retinal implants segment accounted for the highest growth rate in the electroceuticals market, by product, during the forecast period"
Based on product, the electroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, neuromodulators, cochlear implants, and retinal implants. In 2022, the retinal implants segment accounted for the highest growth rate in the electroceuticals market. The main driving factor for retinal implants is the potential to restore vision in individuals with retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration.
"The non-invasive electroceuticals devices segment is projected to experience the highest revenue growth rate during the forecast period"
The electroceuticals market is divided into two segments: implantable electroceutical devices and non-invasive electroceutical devices. In 2022, the noninvasive electroceutical devices segment experienced the highest growth rate. These devices do not require surgical implantation; instead, they use electrical or magnetic fields to stimulate nerves or muscles on the body's surface. They are easy to use, cost-effective, and carry a lower risk of infection. Non-invasive electroceuticals are increasingly being used in the treatment of chronic pain, neurological disorders, and metabolic disorders. Technological advancements in non-invasive electroceuticals, along with increased healthcare expenditure and a rise in the prevalence of chronic diseases, are anticipated to drive the growth of the non-invasive devices segment in the forecast period.
"Asia Pacific: The fastest-growing region in electroceuticals care market"
The global electroceuticals market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to record the highest CAGR during the forecast period. This growth is attributed to factors such as increased healthcare expenditure, rising pharmaceutical research funding, government initiatives to raise awareness about early disease detection, expansion of private-sector hospitals into rural areas in various APAC countries, and the presence of high-growth markets in the region.
The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 28%, Tier 2 - 42%, and Tier 3 -30%
By Designation: C-level - 30%, D-level - 34%, and Others - 36%
By Region: North America - 46%, Europe - 25%, Asia Pacific - 18%, and Rest of the World -11%
Lists of Companies Profiled in the Report:
Medtronic plc (Ireland)
Boston Scientific Corporation (US)
Abbott Laboratories, Inc. (US)
Cochlear Ltd. (Australia)
LivaNova PLC (UK)
MicroPort Scientific Corporation (China)
Sonova Group (Switzerland)
Nevro Corp. (US)
Axonics Modulation Technologies, Inc. (US)
Neuronetics, Inc. (US)
ElectroCore, Inc. (US)
NeuroPace, Inc. (US)
BIOTRONIK (Germany)
Medico S.p.A. (Italy)
Nurotron Biotechnology Co. Ltd. (US)
MED-EL (Austria)
Aleva Neurotherapeutics SA (Switzerland)
NeuroSigma, Inc. (US)
BioWave Corporation (US)
Soterix Medical Inc. (US)
Bioinduction (Amber Therapeutics) (UK)
GiMer Medical (Taiwan)
Cefaly (Belgium)
BioControl Medical (Israel)
tVNS Technologies GmbH (Germany).
Research Coverage:
This research report categorizes the electroceuticals market by products, type, application and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the electroceuticals market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies; contracts, partnerships, agreements, new product launches, mergers and acquisitions, and recent developments associated with the electroceuticals market. Competitive analysis of upcoming startups in the electroceuticals market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall electroceuticals market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the electroceuticals market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the electroceuticals market.
Market Development: Comprehensive information about lucrative markets - the report analyses the electroceuticals market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electroceuticals market.
Competitive Assessment: In-depth assessment of market ranking, growth strategies and product offerings of leading players like Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), and Cochlear Ltd. (Australia) among others in the electroceuticals market strategies.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
1.3 STUDY SCOPE
FIGURE 1 ELECTROCEUTICALS MARKET SEGMENTATION
1.3.1 GEOGRAPHIC SCOPE
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
TABLE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN ELECTROCEUTICALS MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising geriatric population and subsequent growth in prevalence of neurological and cardiovascular disorders
5.2.1.2 Rising government support and funding for neurological disorders
5.2.1.3 Increasing investments and funding for research on CRM devices
5.2.1.4 Increasing focus on development of advanced neuromodulation and cardiac devices
5.2.1.5 Increasing collaborations among device manufacturers, healthcare providers, and research institutes to develop neuromodulation and cardiac devices
5.2.1.6 Availability of reimbursements for neuromodulation, cardiac devices, and cochlear implants
5.2.1.7 Growing prevalence of hearing loss and increasing adoption of smart hearing aids
5.2.2 RESTRAINTS
5.2.2.1 High cost of electroceutical devices
5.2.2.2 Preference for drug therapies over neuromodulation and cardiac products
5.2.2.3 Adverse effects and complications associated with neuromodulation, cardiac devices, and cochlear implants
TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Development of ICDs and MRI-compatible ICDs and CRT-Ds
5.2.3.3 Integration with digital health platforms
5.2.4 CHALLENGES
5.2.4.1 Dearth of trained professionals
5.2.4.2 Challenges associated with battery life and device replacement
5.2.4.3 Complexity and infection issues related to electroceutical devices
5.2.5 TRENDS
5.2.5.1 Role of artificial intelligence (AI) in electroceutical devices
5.2.5.2 Wearable and portable electroceuticals
5.3 PRICING ANALYSIS
TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022)
TABLE 5 AVERAGE SELLING PRICE TREND FOR NEUROMODULATION DEVICES AND PROCEDURES, BY REGION (2022)
5.4 VALUE CHAIN ANALYSIS
FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 21 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
TABLE 106 ASIA PACIFIC: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 107 MIDDLE EAST & AFRICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)
8 ELECTROCEUTICALS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY APPLICATION
TABLE 108 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
8.2.1 ARRHYTHMIA
8.2.1.1 Increasing prevalence of arrhythmia to support market growth
TABLE 109 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY REGION, 2021-2029 (USD MILLION)
TABLE 110 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 111 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 112 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021-2029 (USD MILLION)
8.2.2 HEART FAILURE
8.2.2.1 Rising prevalence of heart-related conditions in older individuals to drive growth
TABLE 113 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY REGION, 2021-2029 (USD MILLION)
TABLE 114 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 115 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021-2029 (USD MILLION)
8.2.3 OTHER CARDIAC PACEMAKER & ICD APPLICATIONS
TABLE 117 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
TABLE 118 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 119 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
8.3 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION
TABLE 121 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
8.3.1 CHRONIC PAIN
8.3.1.1 High incidence of chronic pain to support market growth
TABLE 122 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2021-2029 (USD MILLION)
TABLE 123 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 124 EUROPE: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 125 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021-2029 (USD MILLION)
8.3.2 FAILED BACK SURGERY SYNDROME
8.3.2.1 Increasing incidence of FBSS to drive demand
TABLE 126 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2021-2029 (USD MILLION)
TABLE 127 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 128 EUROPE: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 129 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021-2029 (USD MILLION)
8.3.3 ISCHEMIA
8.3.3.1 High effectiveness of neuromodulation for ischemia treatment to propel market
TABLE 130 SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY REGION, 2021-2029 (USD MILLION)
TABLE 131 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 132 EUROPE: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 133 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021-2029 (USD MILLION)
8.4 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION
TABLE 134 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
8.4.1 PARKINSON'S DISEASE
8.4.1.1 Rising incidence of Parkinson's disease and growing R&D to drive market
TABLE 135 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY REGION, 2021-2029 (USD MILLION)
TABLE 136 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 137 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 138 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2021-2029 (USD MILLION)
8.4.2 TREMORS
8.4.2.1 High efficacy of DBS in treating tremors to drive market
TABLE 139 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2021-2029 (USD MILLION)
TABLE 140 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 141 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 142 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021-2029 (USD MILLION)
8.4.3 DEPRESSION
8.4.3.1 Rising research and clinical studies related to depression treatment to propel market
TABLE 143 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021-2029 (USD MILLION)
TABLE 144 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 145 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
8.4.4 OTHER DBS APPLICATIONS
TABLE 147 DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
TABLE 148 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 149 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 150 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
8.5 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION
TABLE 151 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
8.5.1 URINE INCONTINENCE
8.5.1.1 High incidence of urine incontinence to offer growth opportunities for market players
TABLE 152 SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY REGION, 2021-2029 (USD MILLION)
TABLE 153 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 154 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 155 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
8.5.2 FECAL INCONTINENCE
8.5.2.1 Reduced symptom recurrence with use of SNS to drive demand
TABLE 156 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2021-2029 (USD MILLION)
TABLE 157 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 158 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 159 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
8.6 ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION
TABLE 160 ELECTROCEUTICALS MARKET FOR VAGUS NERVE SIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
8.6.1 EPILEPSY
8.6.1.1 Advantages associated with VNS in epilepsy treatment to propel market
TABLE 161 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2021-2029 (USD MILLION)
TABLE 162 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 163 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 164 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021-2029 (USD MILLION)
8.6.2 OTHER VNS APPLICATIONS
TABLE 165 VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
TABLE 166 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 167 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 168 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
8.7 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION
TABLE 169 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
8.7.1 GASTROPARESIS
8.7.1.1 Reduced hospitalization time associated with GES treatment to drive market
TABLE 170 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2021-2029 (USD MILLION)
TABLE 171 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 172 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 173 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021-2029 (USD MILLION)
8.7.2 OBESITY
8.7.2.1 High prevalence of obesity and risks associated with gastric bypass to propel market
TABLE 174 GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY REGION, 2021-2029 (USD MILLION)
TABLE 175 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 176 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 177 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021-2029 (USD MILLION)
8.8 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION
TABLE 178 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
8.8.1 TREATMENT-RESISTANT DEPRESSION
8.8.1.1 High prevalence of depression to drive market
TABLE 179 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2021-2029 (USD MILLION)
TABLE 180 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 181 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 182 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
8.8.2 OTHER TENS APPLICATIONS
TABLE 183 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
TABLE 184 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, 2021-2029 (USD MILLION)
TABLE 185 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 186 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
8.9 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION
TABLE 187 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION
8.9.1 DEPRESSION
8.9.1.1 High effectiveness of TMS and increased acceptance among patients to drive market
TABLE 188 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021-2029 (USD MILLION)
TABLE 189 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 190 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 191 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
8.9.2 MIGRAINE
8.9.2.1 High prevalence of migraine to support market growth
TABLE 192 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021-2029 (USD MILLION)
TABLE 193 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 194 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 195 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
8.10 ELECTROCEUTICALS MARKET FOR RESPIRATORY ELECTRICAL STIMULATORS, BY APPLICATION
8.10.1 SPINAL CORD INJURY
8.10.1.1 Rising incidence of spinal cord injuries to fuel demand
TABLE 196 RESPIRATORY ELECTRICAL STIMULATORS MARKET FOR SPINAL CORD INJURY, BY REGION, 2021-2029 (USD MILLION)
8.11 ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION
TABLE 197 ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION
8.11.1 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
8.11.1.1 Minimal side effects to drive adoption
TABLE 198 TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY REGION, 2021-2029 (USD MILLION)
TABLE 199 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 200 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 201 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021-2029 (USD MILLION)
8.11.2 MIGRAINE
8.11.2.1 Increasing demand for non-pharmacological treatments to support market growth
TABLE 202 TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021-2029 (USD MILLION)
TABLE 203 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 204 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 205 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
9 ELECTROCEUTICALS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 206 ELECTROCEUTICALS MARKET, BY REGION, 2021-2029 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT
TABLE 207 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 208 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 209 NORTH AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 210 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 211 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 212 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 213 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 214 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 215 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 216 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 217 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 218 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 219 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.2.1 US
9.2.1.1 Rising prevalence of cardiovascular and neurological disorders to drive market
TABLE 220 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 221 US: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 222 US: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 223 US: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 224 US: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 225 US: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 226 US: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 227 US: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 228 US: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 229 US: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 230 US: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 231 US: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising healthcare expenditure and increasing prevalence of chronic diseases to drive demand
TABLE 232 NEUROLOGICAL CONDITIONS PREVALENT IN CANADA, 2016-2031
TABLE 233 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 234 CANADA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 235 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 236 CANADA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 237 CANADA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 238 CANADA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 239 CANADA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 240 CANADA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 241 CANADA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 242 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 243 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 244 CANADA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.2.3 NORTH AMERICA: RECESSION IMPACT
9.3 EUROPE
TABLE 245 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 246 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 247 EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 248 EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 249 EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 250 EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 251 EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 252 EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 253 EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 254 EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 255 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 256 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 257 EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Presence of favorable reimbursement policies to drive market
TABLE 258 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 259 GERMANY: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 260 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 261 GERMANY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 262 GERMANY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 263 GERMANY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 264 GERMANY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 265 GERMANY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 266 GERMANY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 267 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 268 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 269 GERMANY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising support from government and private organizations to fuel market growth
TABLE 270 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 271 UK: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 272 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 273 UK: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 274 UK: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 275 UK: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 276 UK: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 277 UK: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 278 UK: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 279 UK: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 280 UK: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 281 UK: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Promising healthcare reforms to drive market
TABLE 282 FRANCE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 283 FRANCE: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 284 FRANCE: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 285 FRANCE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 286 FRANCE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 287 FRANCE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 288 FRANCE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 289 FRANCE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 290 FRANCE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 291 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 292 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 293 FRANCE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Easy access to healthcare services to create lucrative opportunities for market growth
TABLE 294 ITALY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 295 ITALY: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 296 ITALY: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 297 ITALY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 298 ITALY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 299 ITALY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 300 ITALY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 301 ITALY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 302 ITALY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 303 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 304 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 305 ITALY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing number of conferences and awareness programs to support market growth
TABLE 306 SPAIN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 307 SPAIN: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 308 SPAIN: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 309 SPAIN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 310 SPAIN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 311 SPAIN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 312 SPAIN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 313 SPAIN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 314 SPAIN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 315 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 316 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 317 SPAIN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 318 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 319 REST OF EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 320 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 321 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 322 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 323 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 324 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 325 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 326 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 327 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 328 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 329 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.3.7 EUROPE: RECESSION IMPACT
9.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT
TABLE 330 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 331 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 332 ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 333 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 334 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 335 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 336 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 337 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 338 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 339 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 340 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 341 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 342 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Increasing prevalence of cardiovascular and neurological disorders to drive demand
TABLE 343 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 344 JAPAN: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 345 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 346 JAPAN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 347 JAPAN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 348 JAPAN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 349 JAPAN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 350 JAPAN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 351 JAPAN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 352 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 353 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 354 JAPAN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Rising geriatric population to support market growth
TABLE 355 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 356 CHINA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 357 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 358 CHINA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 359 CHINA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 360 CHINA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 361 CHINA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 362 CHINA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 363 CHINA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 364 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 365 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 366 CHINA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Developments in healthcare structure to propel market
TABLE 367 INDIA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 368 INDIA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 369 INDIA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 370 INDIA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 371 INDIA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 372 INDIA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 373 INDIA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 374 INDIA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 375 INDIA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 376 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 377 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 378 INDIA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 379 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 380 REST OF ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 381 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 382 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 383 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 384 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 385 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 386 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 387 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 388 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 389 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 390 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.4.5 ASIA PACIFIC: RECESSION IMPACT
9.5 LATIN AMERICA
9.5.1 RAPIDLY GROWING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
TABLE 391 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 392 LATIN AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 393 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 394 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 395 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 396 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 397 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 398 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 399 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 400 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 401 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 402 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.5.2 LATIN AMERICA: RECESSION IMPACT
9.6 MIDDLE EAST & AFRICA
TABLE 403 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY REGION, 2021-2029 (USD MILLION)
TABLE 404 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 405 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 406 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 407 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 408 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 409 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 410 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 411 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 412 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 413 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 414 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 415 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
9.6.1 GCC COUNTRIES
9.6.1.1 Advances in healthcare sector to support market growth
TABLE 434 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
11.1.3 ABBOTT
TABLE 435 ABBOTT: BUSINESS OVERVIEW
FIGURE 37 ABBOTT: COMPANY SNAPSHOT (2022)
11.1.4 LIVANOVA PLC
TABLE 436 LIVANOVA PLC: BUSINESS OVERVIEW
FIGURE 38 LIVANOVA PLC: COMPANY SNAPSHOT (2022)
11.1.5 COCHLEAR LTD.
TABLE 437 COCHLEAR LTD.: BUSINESS OVERVIEW
FIGURE 39 COCHLEAR LTD.: COMPANY SNAPSHOT (2023)
11.1.6 MICROPORT SCIENTIFIC CORPORATION
TABLE 438 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 40 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
11.1.7 SONOVA
TABLE 439 SONOVA: BUSINESS OVERVIEW
FIGURE 41 SONOVA GROUP: COMPANY SNAPSHOT (2022)
11.1.8 NEVRO CORP.
TABLE 440 NEVRO CORP.: BUSINESS OVERVIEW
FIGURE 42 NEVRO CORP.: COMPANY SNAPSHOT (2022)
11.1.9 AXONICS, INC.
TABLE 441 AXONICS, INC.: BUSINESS OVERVIEW
FIGURE 43 AXONICS INC.: COMPANY SNAPSHOT (2022)
11.1.10 NEURONETICS
TABLE 442 NEURONETICS: BUSINESS OVERVIEW
FIGURE 44 NEURONETICS: COMPANY SNAPSHOT (2022)
11.1.11 ELECTROCORE, INC.
TABLE 443 ELECTROCORE, INC.: BUSINESS OVERVIEW
FIGURE 45 ELECTROCORE, INC.: COMPANY SNAPSHOT (2022)
11.1.12 NEUROPACE, INC.
TABLE 444 NEUROPACE, INC.: BUSINESS OVERVIEW
FIGURE 46 NEUROPACE, INC.: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 BIOTRONIK
TABLE 445 BIOTRONIK: COMPANY OVERVIEW
11.2.2 MEDICO S.R.L.
TABLE 446 MEDICO S.R.L.: COMPANY OVERVIEW
11.2.3 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
TABLE 447 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
11.2.4 MED-EL
TABLE 448 MED-EL: COMPANY OVERVIEW
11.2.5 ALEVA NEUROTHERAPEUTICS
TABLE 449 ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW
11.2.6 NEUROSIGMA, INC.
TABLE 450 NEUROSIGMA, INC.: COMPANY OVERVIEW
11.2.7 BIOWAVE CORPORATION
TABLE 451 BIOWAVE CORPORATION: COMPANY OVERVIEW
11.2.8 SOTERIX MEDICAL INC.
TABLE 452 SOTERIX MEDICAL INC.: COMPANY OVERVIEW
11.2.9 BIOINDUCTION (AMBER THERAPEUTICS)
TABLE 453 BIOINDUCTION (AMBER THERAPEUTICS): COMPANY OVERVIEW
11.2.10 GIMER MEDICAL
TABLE 454 GIMER MEDICAL: COMPANY OVERVIEW
11.2.11 CEFALY
TABLE 455 CEFALY: COMPANY OVERVIEW
11.2.12 BIOCONTROL MEDICAL
TABLE 456 BIOCONTROL MEDICAL: COMPANY OVERVIEW
11.2.13 TVNS HEALTH GMBH
TABLE 457 TVNS HEALTH GMBH: COMPANY OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.
